Jian Xu - Search Results

Year	Number of Results
1987	1
1997	1
2002	28
2003	39
2004	42
2005	60
2006	73
2007	67
2008	61
2009	109
2010	97
2011	95
2012	133
2013	179
2014	207
2015	196
2016	206
2017	219
2018	251
2019	264
2020	286
2021	316
2022	333
2023	270

1

Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation.

Zhong W, Rao Z, Xu J, Sun Y, Hu H, Wang P, Xia Y, Pan X, Tang W, Chen Z, Zhou H, Wang X. Zhong W, et al. Among authors: xu j. Aging Cell. 2022 Jun;21(6):e13622. doi: 10.1111/acel.13622. Epub 2022 May 22. Aging Cell. 2022. PMID: 35599014 Free PMC article.

2

Prevalence and risk of atrial fibrillation in China: A national cross-sectional epidemiological study.

Shi S, Tang Y, Zhao Q, Yan H, Yu B, Zheng Q, Li Y, Zheng L, Yuan Y, Zhong J, Xu J, Wu Y, Xu J, Chen L, Li S, Jiang J, Wang J, Fan J, Chen M, Tang B, Li W, Wu Q, Shi B, Zhou S, Zhao X, Yin Y, Zhang Z, Zhong G, Han X, Liu F, Wu M, Gao L, Yang B, Huang H, Huang C; China Atrial Fibrillation Center Project Team). Shi S, et al. Among authors: xu j. Lancet Reg Health West Pac. 2022 Apr 11;23:100439. doi: 10.1016/j.lanwpc.2022.100439. eCollection 2022 Jun. Lancet Reg Health West Pac. 2022. PMID: 35800039 Free PMC article.

3

Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors.

Zhang X, Lao M, Xu J, Duan Y, Yang H, Li M, Ying H, He L, Sun K, Guo C, Chen W, Jiang H, Zhang X, Bai X, Liang T. Zhang X, et al. Among authors: xu j. J Immunother Cancer. 2022 Mar;10(3):e003982. doi: 10.1136/jitc-2021-003982. J Immunother Cancer. 2022. PMID: 35260434 Free PMC article.

4

Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis.

He Z, Wang J, Zhu C, Xu J, Chen P, Jiang X, Chen Y, Jiang J, Sun C. He Z, et al. Among authors: xu j. Cancer Lett. 2022 Nov 1;548:215751. doi: 10.1016/j.canlet.2022.215751. Epub 2022 Jun 16. Cancer Lett. 2022. PMID: 35718269

5

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).

Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY, Sun JH, Jin ZC, Chen JJ, Ge NJ, Ding WB, Li WH, Huang JH, Mu W, Gu SZ, Li JP, Zhao H, Wen SW, Lei YM, Song YS, Yuan CW, Wang WD, Huang M, Zhao W, Wu JB, Wang S, Zhu X, Han JJ, Ren WX, Lu ZM, Xing WG, Fan Y, Lin HL, Zhang ZS, Xu GH, Hu WH, Tu Q, Su HY, Zheng CS, Chen Y, Zhao XY, Fang ZT, Wang Q, Zhao JW, Xu AB, Xu J, Wu QH, Niu HZ, Wang J, Dai F, Feng DP, Li QD, Shi RS, Li JR, Yang G, Shi HB, Ji JS, Liu YE, Cai Z, Yang P, Zhao Y, Zhu XL, Lu LG, Teng GJ; CHANCE001 Investigators. Zhu HD, et al. Among authors: xu j. Signal Transduct Target Ther. 2023 Feb 8;8(1):58. doi: 10.1038/s41392-022-01235-0. Signal Transduct Target Ther. 2023. PMID: 36750721 Free PMC article.

6

LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2.

Wang J, He Z, Liu X, Xu J, Jiang X, Quan G, Jiang J. Wang J, et al. Among authors: xu j. Cell Death Dis. 2022 Aug 18;13(8):718. doi: 10.1038/s41419-022-05172-2. Cell Death Dis. 2022. PMID: 35977942 Free PMC article.

7

The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis.

Zhang LX, Gao J, Long X, Zhang PF, Yang X, Zhu SQ, Pei X, Qiu BQ, Chen SW, Lu F, Lin K, Xu JJ, Wu YB. Zhang LX, et al. Among authors: xu jj. Mol Cancer. 2022 May 7;21(1):110. doi: 10.1186/s12943-022-01586-w. Mol Cancer. 2022. PMID: 35525959 Free PMC article.

8

Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies.

Pang L, Gan C, Xu J, Jia Y, Chai J, Huang R, Li A, Ge H, Yu S, Cheng H. Pang L, et al. Among authors: xu j. Cancers (Basel). 2022 Nov 22;14(23):5727. doi: 10.3390/cancers14235727. Cancers (Basel). 2022. PMID: 36497209 Free PMC article. Review.

9

Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance.

Lyu J, Liu Y, Gong L, Chen M, Madanat YF, Zhang Y, Cai F, Gu Z, Cao H, Kaphle P, Kim YJ, Kalkan FN, Stephens H, Dickerson KE, Ni M, Chen W, Patel P, Mims AS, Borate U, Burd A, Cai SF, Yin CC, You MJ, Chung SS, Collins RH, DeBerardinis RJ, Liu X, Xu J. Lyu J, et al. Among authors: xu j. Cancer Discov. 2023 Jan 9;13(1):170-193. doi: 10.1158/2159-8290.CD-21-1661. Cancer Discov. 2023. PMID: 36222845 Free PMC article.

10

Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer.

Yang H, Zhang X, Lao M, Sun K, He L, Xu J, Duan Y, Chen Y, Ying H, Li M, Guo C, Lu Q, Wang S, Su W, Liang T, Bai X. Yang H, et al. Among authors: xu j. Cell Death Differ. 2023 Feb;30(2):560-575. doi: 10.1038/s41418-022-01102-z. Epub 2022 Dec 20. Cell Death Differ. 2023. PMID: 36539510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

3,136 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

3,136 results

Results by year